- Home
- ACRV vs PPSI Comparison
ACRV vs PPSI Comparison
Compare ACRV & PPSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRV
- PPSI
- Stock Information
- Founded
- ACRV 2018
- PPSI 2008
- Country
- ACRV United States
- PPSI United States
- Employees
- ACRV N/A
- PPSI N/A
- Industry
- ACRV Medicinal Chemicals and Botanical Products
- PPSI Electrical Products
- Sector
- ACRV Health Care
- PPSI Industrials
- Exchange
- ACRV Nasdaq
- PPSI Nasdaq
- Market Cap
- ACRV 47.8M
- PPSI 46.6M
- IPO Year
- ACRV 2022
- PPSI N/A
- Fundamental
- Price
- ACRV $1.87
- PPSI $4.19
- Analyst Decision
- ACRV Buy
- PPSI Strong Buy
- Analyst Count
- ACRV 6
- PPSI 1
- Target Price
- ACRV $17.75
- PPSI $12.00
- AVG Volume (30 Days)
- ACRV 1.1M
- PPSI 125.8K
- Earning Date
- ACRV 11-07-2025
- PPSI 11-13-2025
- Dividend Yield
- ACRV N/A
- PPSI 35.97%
- EPS Growth
- ACRV N/A
- PPSI N/A
- EPS
- ACRV N/A
- PPSI 2.91
- Revenue
- ACRV N/A
- PPSI $31,279,000.00
- Revenue This Year
- ACRV N/A
- PPSI $27.32
- Revenue Next Year
- ACRV $805.34
- PPSI $16.14
- P/E Ratio
- ACRV N/A
- PPSI $1.41
- Revenue Growth
- ACRV N/A
- PPSI 105.82
- 52 Week Low
- ACRV $1.05
- PPSI $2.25
- 52 Week High
- ACRV $8.74
- PPSI $6.80
- Technical
- Relative Strength Index (RSI)
- ACRV 48.13
- PPSI 44.14
- Support Level
- ACRV $1.91
- PPSI $4.36
- Resistance Level
- ACRV $2.46
- PPSI $4.78
- Average True Range (ATR)
- ACRV 0.17
- PPSI 0.26
- MACD
- ACRV -0.02
- PPSI -0.06
- Stochastic Oscillator
- ACRV 15.69
- PPSI 36.73
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.
About PPSI Pioneer Power Solutions Inc.
Pioneer Power Solutions Inc designs, manufactures, integrates, services, and sells distributed energy resources, on-site and mobile power generation equipment, and a platform of mobile electric vehicle (EV) charging solutions.. Its principal products and services include custom-engineered electrical transformers, switchgear and engine-generator sets and controls, complemented by a national field-service network to maintain and repair power generation assets.